Wealth Architects, LLC - LINEAGE CELL THERAPEUTICS IN ownership

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 102 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 2.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealth Architects, LLC ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q1 2022$25,000
-50.0%
16,100
-8.0%
0.00%
-60.0%
Q2 2021$50,000
-41.2%
17,500
-51.4%
0.01%
-44.4%
Q1 2021$85,000
+165.6%
36,000
+100.0%
0.02%
+157.1%
Q4 2020$32,00018,0000.01%
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q1 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 34,935,485$41,223,8723.66%
Raffles Associates 1,587,739$1,873,5322.48%
Defender Capital, LLC. 5,184,510$6,117,7222.22%
Prescott General Partners LLC 1,851,851$2,185,1840.14%
DCF Advisers, LLC 82,751$97,6460.05%
Beirne Wealth Consulting Services, LLC 45,000$63,4500.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 781,766$922,4840.02%
Fort Sheridan Advisors LLC 83,931$99,0390.02%
MAI Capital Management 954,688$1,126,5320.02%
Piscataqua Savings Bank 12,499$14,6230.01%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders